Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) – a study protocol

被引：0
|
作者：
Dennis Schrijnders
Geertruida H. de Bock
Sebastiaan T. Houweling
Kornelis J. J. van Hateren
Klaas H. Groenier
Jeffrey A. Johnson
Henk J. G. Bilo
Nanne Kleefstra
Gijs W. D. Landman
机构：
[1] Isala,Diabetes Centre
[2] Langerhans Medical Research Group,Department of Epidemiology
[3] University of Groningen,Department of General Practice
[4] University Medical Center Groningen,Department of Internal Medicine
[5] University of Groningen,Department of Internal Medicine
[6] University Medical Center Groningen,Department of Internal Medicine
[7] School of Public Health,undefined
[8] University of Alberta,undefined
[9] University of Groningen,undefined
[10] University Medical Center Groningen,undefined
[11] Isala,undefined
[12] Gelre Hospital,undefined
来源：
BMC Cancer | / 17卷
关键词：
Type 2 diabetes; Sulfonylureas; Cancer; Within-class differences;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) - a study protocol
    Schrijnders, Dennis
    de Bock, Geertruida H.
    Houweling, Sebastiaan T.
    van Hateren, Kornelis J. J.
    Groenier, Klaas H.
    Johnson, Jeffrey A.
    Bilo, Henk J. G.
    Kleefstra, Nanne
    Landman, Gijs W. D.
    BMC CANCER, 2017, 17
  • [2] Sulfonylurea and Cancer Risk Among Patients With Type 2 Diabetes: A Population-Based Cohort Study
    Zhao, Houyu
    Liu, Zhike
    Zhuo, Lin
    Shen, Peng
    Lin, Hongbo
    Sun, Yexiang
    Zhan, Siyan
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [3] The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment
    Pan, Sheng-Wei
    Yen, Yung-Feng
    Kou, Yu Ru
    Chuang, Pei-Hung
    Su, Vincent Yi-Fong
    Feng, Jia-Yih
    Chan, Yu-Jiun
    Su, Wei-Juin
    CHEST, 2018, 153 (06) : 1347 - 1357
  • [4] Sulfonylurea use and the risk of hospital readmission in patients with type 2 diabetes
    Heaton, Pamela C.
    Desai, Vibha C. A.
    Kelton, Christina M. L.
    Rajpathak, Swapnil N.
    BMC ENDOCRINE DISORDERS, 2016, 16
  • [5] Sulfonylurea use and the risk of hospital readmission in patients with type 2 diabetes
    Pamela C. Heaton
    Vibha C. A. Desai
    Christina M. L. Kelton
    Swapnil N. Rajpathak
    BMC Endocrine Disorders, 16
  • [6] Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta-Analysis
    Soranna, Davide
    Scotti, Lorenza
    Zambon, Antonella
    Bosetti, Cristina
    Grassi, Guido
    Catapano, Alberico
    La Vecchia, Carlo
    Mancia, Giuseppe
    Corrao, Giovanni
    ONCOLOGIST, 2012, 17 (06) : 813 - 822
  • [7] Weight Changes in Type 2 Diabetes and Cancer Risk: A Latent Class Trajectory Model Study
    Jensen, Britt W.
    Watson, Charlotte
    Geifman, Nophar
    Baker, Jennifer L.
    Badrick, Ellena
    Renehan, Andrew G.
    OBESITY FACTS, 2022, 15 (02) : 150 - 159
  • [8] Cancer risk in patients with type 2 diabetes mellitus and their relatives
    Liu, Xiangdong
    Hemminki, Kari
    Forsti, Asta
    Sundquist, Kristina
    Sundquist, Jan
    Ji, Jianguang
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (04) : 903 - 910
  • [9] Intensive glucose control and risk of cancer in patients with type 2 diabetes
    G. Stefansdottir
    S. Zoungas
    J. Chalmers
    A. P. Kengne
    M. J. Knol
    H. G. M. Leufkens
    A. Patel
    M. Woodward
    D. E. Grobbee
    M. L. De Bruin
    Diabetologia, 2011, 54 : 1608 - 1614
  • [10] Intensive glucose control and risk of cancer in patients with type 2 diabetes
    Stefansdottir, G.
    Zoungas, S.
    Chalmers, J.
    Kengne, A. P.
    Knol, M. J.
    Leufkens, H. G. M.
    Patel, A.
    Woodward, M.
    Grobbee, D. E.
    De Bruin, M. L.
    DIABETOLOGIA, 2011, 54 (07) : 1608 - 1614
12345